HomeCompareXXMMF vs MRK

XXMMF vs MRK: Dividend Comparison 2026

XXMMF yields 3571.43% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 XXMMF wins by $2410861919878.47M in total portfolio value
10 years
XXMMF
XXMMF
● Live price
3571.43%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2410861919878.53M
Annual income
$2,285,003,389,352,781,300.00
Full XXMMF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — XXMMF vs MRK

📍 XXMMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodXXMMFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, XXMMF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
XXMMF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XXMMF
Annual income on $10K today (after 15% tax)
$303,571.43/yr
After 10yr DRIP, annual income (after tax)
$1,942,252,880,949,864,200.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, XXMMF beats the other by $1,942,252,880,949,855,700.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XXMMF + MRK for your $10,000?

XXMMF: 50%MRK: 50%
100% MRK50/50100% XXMMF
Portfolio after 10yr
$1205430959939.29M
Annual income
$1,142,501,694,676,395,500.00/yr
Blended yield
94.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

XXMMF
No analyst data
Altman Z
-55.4
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XXMMF buys
0
MRK buys
0
No recent congressional trades found for XXMMF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricXXMMFMRK
Forward yield3571.43%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$2410861919878.53M$56.8K
Annual income after 10y$2,285,003,389,352,781,300.00$9,798.13
Total dividends collected$2402234622286.96M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: XXMMF vs MRK ($10,000, DRIP)

YearXXMMF PortfolioXXMMF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$367,843$357,142.86$11,206$366.19+$356.6KXXMMF
2$12,671,391$12,277,798.97$12,650$502.35+$12.66MXXMMF
3$408,832,799$395,274,410.34$14,407$694.19+$408.82MXXMMF
4$12,356,356,289$11,918,905,194.31$16,585$967.82+$12356.34MXXMMF
5$349,885,767,337$336,664,466,108.04$19,342$1,363.89+$349885.75MXXMMF
6$9,283,796,217,812$8,909,418,446,760.99$22,913$1,947.19+$9283796.19MXXMMF
7$230,868,855,425,769$220,935,193,472,710.20$27,662$2,823.89+$230868855.40MXXMMF
8$5,381,798,251,219,442$5,134,768,575,913,869.00$34,159$4,173.35+$5381798251.19MXXMMF
9$117,624,794,883,873,220$111,866,270,755,068,420.00$43,337$6,308.80+$117624794883.83MXXMMF
10$2,410,861,919,878,526,000$2,285,003,389,352,781,300.00$56,776$9,798.13+$2410861919878.47MXXMMF

XXMMF vs MRK: Complete Analysis 2026

XXMMFStock

Ximen Mining Corp. engages in the acquisition, exploration, and evaluation of mineral properties in Canada. The company primarily explores for gold, silver, lead, and zinc deposits. Its principal project is the Brett Epithermal Gold Project located in British Columbia. The company also acquires 100% interest in the Wild Horse Creek property that consists of 139 mineral claims covering an area of approximately 12,767 hectares located in southern British Columbia. It has option to acquire the Kenville Gold Mine project located west of Nelson, British Columbia. The company was formerly known as Elm Tree Minerals Inc. and changed its name to Ximen Mining Corp. in September 2013. Ximen Mining Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.

Full XXMMF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this XXMMF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XXMMF vs SCHDXXMMF vs JEPIXXMMF vs OXXMMF vs KOXXMMF vs MAINXXMMF vs JNJXXMMF vs ABBVXXMMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.